Adam Walker’s Pharma Prescribed Podcast

Ashish Rishi on The Patients Clinical Trials Leave Out — and the Evidence That Counts Them In | Pharma Prescribed 
Ashish Rishi is Founder and CEO of Unwritten Health, the Manchester-based patient experience data platform working to make life science's evidence reflect the people it's meant to serve.
His mission is unsentimental — and it starts with his father. At 17, Ash watched his dad spend three years fighting for a GP referral for worsening back and bone pain. The eventual diagnosis was terminal prostate cancer, delivered to an 18-year-old and his mother — for whom English is a fourth language — in a two-minute conversation and a flyer, with no family network to turn to. His father lived six more years and passed away three months before Ash's graduation.
That experience became a company. In this episode Ash explains "inclusion debt" — his term for how bias compounds at every stage of drug development: unmet need defined without the real patient voice, multi-billion-pound programmes built on focus groups of eight to ten patient experts, recruitment budgets thrown at social ads that reach the already-reachable, and value dossiers that carry only the majority narrative. By market access, it's too late to fix.
The Patients Clinical Trials Leave Out — and the Evidence That Counts Them In
His answer is Equity Engine: a 6,000-strong UK participant panel profiled across the social determinants of health, built through gurdwaras, mosques, temples, churches and community groups, generating longitudinal lived-experience data at a scale focus groups never could — and turning it into submission-ready evidence.
Honest about being a "failed scientist," about burnout and anger, and about the trust he has to earn in every room. A powerful conversation about fixing inequity as an evidence and design problem, not just a moral one.
🎧 LISTEN TO THE AUDIOSpotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjtiApple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcastPodbean: https://pharmaprescribed.podbean.com
Youtube: http://www.youtube.com/@pharmaprescribedpodcastFull transcript and episode notes: https://pharmaprescribed.com/episodes
⏱️ CHAPTERS0:00 Intro0:35 Meet Ashish Rishi1:00 A father's diagnosis3:00 From neuroscience to comms4:00 The clinical trial wake-up call7:00 The Demand Diversity movement9:00 Building Equity Engine12:00 Inclusion debt explained15:00 UK data fragmentation17:00 Barriers and misinformation19:00 AI-powered patient insights26:00 Neurodivergent-friendly trials28:00 Quickfire round30:00 Golden rule and wrap up
👤 ABOUT ASHISH RISHIFounder and CEO of Unwritten Health and creator of the Equity Engine platform. Neuroscience MSc and former health communications specialist. Sits on the scientific advisory board of IHI READ-Y (an EU Innovative Health Initiative / Horizon Europe programme advancing inclusive clinical research) and the equity committee of the US Prader-Willi Syndrome Association. Advocate for re-engineering health inequity as an evidence and design problem.💼 Search "Ashish Rishi" on LinkedIn🌐 https://www.unwrittenhealth.com
🎙️ ABOUT PHARMA PRESCRIBEDPharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker.🌐 https://pharmaprescribed.com▶️ https://www.youtube.com/@pharmaprescribedpodcast💼 https://www.linkedin.com/in/adamwalkerbiometrics🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast
#AshishRishi #UnwrittenHealth #InclusionDebt #HealthEquity #ClinicalTrials #ClinicalTrialDiversity #PharmaPrescribed #PatientExperience #SocialDeterminantsOfHealth #RWE #HealthInequality

Louise Callin on dementia, photos sparking conversation & making care more human | Pharma Prescribed
Louise Callin — founder and CEO of ReelLife Conversations — joins Adam Walker for a warm and moving conversation about dementia, human connection and building technology that makes care more human, not less.
After nearly 30 years leading technology and transformation for global corporations including American Express, Louise left to build something with more direct impact. Her mother's dementia journey inspired the idea: photos aren't a memory test, they're a conversation waiting to happen. ReelLife Conversations uses AI to turn family photographs into dementia-friendly conversation prompts — analysing each picture for colours, objects and places, then linking one photo naturally to the next. She's since secured venture capital investment and is building partnerships across the UK and internationally.
Adam and Louise met at a conference — and her energy is unmistakable.
🎧 LISTEN ON YOUR PREFERRED APPSpotify → https://open.spotify.com/search/Louise+Callin+pharma+prescribed/episodes ⚠️ SWAPApple Podcasts → https://podcasts.apple.com/gb/search?term=Louise+Callin+pharma+prescribed ⚠️ SWAPAmazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcastPodbean → https://pharmaprescribed.podbean.com/
Youtube → https://youtu.be/wq1GShCpCYE 
📖 WHAT WE COVER- The superpower Louise didn't know she had — linking one photo to the next in real time- Why photos should never be a memory test: "Do you remember when?" versus "I remember when"- The green top story — how colour, not context, unlocks connection- Turning physical albums into digital assets that work for dementia- Accessible design with no standard to follow: fear-free buttons, no menus, opens straight to use- How the app works: facial recognition, family admin naming, AI conversation prompts- Why each photo links to the next to support natural conversation flow- The carer as the third leg of the stool — and why social care struggles with retention- Louise's mum's journey — and how love led her to quietly cover up early symptoms- Why dementia statistically affects women more — as patients and as primary carers- Dr.Tommy Wood on sleep, supply and stimulation — the non-pharmacological approach- Securing VC investment for a values-driven, volume-based, low-subscription model- Sailing, mind maps and "common sense is not very common"
⏱️ CHAPTERS0:00 Introduction & podcast mission1:00 Meet Louise Callin — founder of ReelLife Conversations1:30 Mission: technology that makes care more human2:00 Her mother's dementia journey and the inspiration2:30 Photos spark conversation — the coffee table superpower4:00 Why the carer couldn't use the photos alone5:00 Colours, objects and places — not just faces6:00 Photos are a conversation waiting to happen8:00 No memory tests: "Do you remember" versus "I remember"9:00 The green top and turning language around11:00 From analogue albums to digital assets12:00 Accessible design for dementia — no written standard13:00 Fear-free buttons and opening straight into use14:00 Designed for two people, side by side15:00 The family admin portal and uploading photos16:00 Facial recognition, naming and location data17:00 AI conversation prompts — the game changer18:00 Linking each photo to the next19:00 The carer as stimulus — the third leg of the stool20:00 Every journey is unique — Uncle Geoff's story22:00 Louise's mum: covering up early symptoms out of love24:00 Social connection as critical — not surfacing memories26:00 From corporate life to founder — securing funding28:00 The volume model: small subscription, huge need30:00 A values-driven business31:00 Women and caregiving — menopause, sleep and stress34:00 Women outliving men and the caregiving needle35:00 Dementia at the forefront, like mental health before it36:00 From pharmacological to non-pharmacological care37:30 Quick-fire: I matter too38:30 The water, sailing and a fish in a previous life40:00 Golden rule: common sense is not very common41:00 reellifeconversations.com and closing thanks
👤 ABOUT LOUISE CALLINFounder and CEO of ReelLife Conversations, a social care technology company helping families, carers and providers create meaningful conversations for people living with dementia. Nearly 30 years in technology and transformation.🌐 https://www.reellifeconversations.com💼 Search "Louise Callin" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBEDLong-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.🌐 https://pharmaprescribed.com💼 https://www.linkedin.com/in/adamwalkerbiometrics
#LouiseCallin #ReelLifeConversations #Dementia #DementiaCare #PharmaPrescribed #AdamWalker #SocialCare #NonPharmacological #CaregiverSupport #WomenAndDementia #DigitalHealth #HumanConnection #Alzheimers #DementiaFriendly #Wellbeing

Andreas Beust on how a small CRO covers the globe without growing | Pharma Prescribed
Andreas Beust is CEO and Managing Director of GCP Service International, a Bremen-based CRO working across medicinal products, medical devices and in vitro diagnostics. He's also President of ACROS — the Association of International CROs — and a guest lecturer at the University of Bremen.
He started on the biostatistics desk. He's now running the company, elected by a leader who — not yet 50 — went looking for a successor because clinical research moves too fast to leave succession to chance.
In this episode Andreas makes complex things accessible, which is his stated mission. He explains the ACROS model: ten similarly-sized, like-minded CROs from the US to Europe, the Middle East, India, China and Australia, who agree that once a partner joins, their country is off-limits to the others. It lets a small CRO run trials globally — 20 concurrent studies across Spain, Italy and Portugal through one trusted partner — without ballooning into the kind of large, rigid, expensive organisation that can't serve smaller sponsors. Grow together, not bigger.
He's refreshingly frank on AI: a lot of overpromise and underdeliver, quarter-of-a-million-per-seat licence fees that no small or mid-size company can pay, and real but modest gains in medical writing, programming and knowledge capture — always human in the loop.
And he's honest about the thing that actually drives growth: discomfort. Curiosity, listening first, and putting yourself in the shop window of the unknown.
An optimistic, grounded conversation about how the human end of this industry actually works — and how to break into it.
🎧 LISTEN TO THE AUDIOSpotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjtiApple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcastPodbean: https://pharmaprescribed.podbean.comFull transcript and episode notes: https://pharmaprescribed.com/episodes
⏱️ CHAPTERS0:00 Intro0:35 Meet Andreas Beust3:00 From the biostats desk to CEO7:00 Podcasting, curiosity and listening first11:00 Breaking into clinical research16:00 Advice for young talent21:00 Hiring for attitude23:00 Leading without ego26:00 A flexibility mindset27:00 Building the ACROS alliance30:00 The presidency and the mission35:00 A communal growth model37:00 AI in clinical trials — a reality check42:00 Compliance, costs and human in the loop44:00 Hope amid uncertainty46:00 Quickfire round50:00 Final takeaways
👤 ABOUT ANDREAS BEUSTCEO and Managing Director of GCP Service International (Bremen). President of ACROS, the Association of International CROs. Guest lecturer at the University of Bremen. Biologist by training who joined GCP Service in the biostatistics department and rose to lead the company through its international expansion. Advocate for accessible clinical research and for training new talent from the ground up.💼 Search "Andreas Beust" on LinkedIn🌐 https://www.gcp-service.com
🎙️ ABOUT PHARMA PRESCRIBEDPharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker.🌐 https://pharmaprescribed.com▶️ https://youtu.be/GxVq88C6ChA💼 https://www.linkedin.com/in/adamwalkerbiometrics🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast
#AndreasBeust #GCPService #ACROS #CRO #ClinicalResearch #ClinicalTrials #PharmaPrescribed #AIinPharma #ClinicalTrialCareers #GCP #ContractResearch

Graham Allcott on Kind, Psychological Safety & the Quiet Power of Kindness | Pharma Prescribe
Graham Allcott — bestselling author of How to Be a Productivity Ninja and Kind: The Quiet Power of Kindness at Work — joins Adam Walker for a conversation about why the ruthless-boss archetype is scientifically wrong.
Graham founded Think Productive, now operating across the UK, USA, Canada, Australia and the Netherlands. His latest book won the 2025 Leadership Book of the Year from the Institute of Leadership and a Business Book Award. His argument is simple and evidence-backed: kindness builds trust, trust builds psychological safety, and psychologically safe teams outperform everyone else.
Adam and Graham first met at the Sussex University Kindness Conference. This is the conversation that followed.
🎧 LISTEN ON YOUR PREFERRED APP Spotify → https://open.spotify.com/episode/04glB17p7bBWVmLjlwIO7z?si=WfiLpCsPQuatGlGcV2_NQQ Apple Podcasts → https://podcasts.apple.com/gb/podcast/graham-allcott-on-kind-psychological-safety-the-quiet/id1829715970?i=1000778402287 Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/episodes/dd83fbdb-4053-468f-8486-9e346073b5f6/adam-walker%E2%80%99s-pharma-prescribed-podcast-graham-allcott-on-kind-psychological-safety-the-quiet-power-of-kindness-pharma-prescribed Podbean → https://pharmaprescribed.podbean.com/
Youtube → https://youtu.be/1i1_TIZRBmI 
📖 WHAT WE COVER- Why we got the success archetype wrong — Mr Burns, Dragon's Den and the myth of the ruthless leader- "Trust and kindness are our rocket fuel" — the company value that became a book- How trust eliminates due diligence — and the Apple purchase analogy- Why organisations without shareholders find kindness easier: Timpson, Richer Sounds, Reed- James Timpson: "The easiest way to make the numbers go up is to flog everybody"- Why charities are often the least kind places to work- The biggest source of accidental unkindness is busyness- The kindness window: why the opportunity closes the moment you notice it- Slowness isn't about speed, it's about savouring- Erling Kagge, the South Pole and the apple that connected him to the tree- How Seth Godin blurbed the book — and the watermark that nearly stopped it- Kindness starts with you: abundance versus scarcity- DJing jazz, funk and soul at Brighton Sundae
⏱️ CHAPTERS0:00 Introduction & podcast mission1:00 Meet Graham Allcott1:30 The mission: thinking differently about work2:00 Why the success archetype is scientifically wrong3:00 Meeting at the Sussex Kindness Conference4:00 The bridge between productivity and kindness4:30 "Trust and kindness are our rocket fuel"5:00 Culture without a water cooler6:00 Psychological safety and what the research shows8:00 Trust eliminates due diligence — the Apple analogy9:00 What happens when trust is lost10:00 Scandinavian workplaces, hygge and Copenhagen12:00 The shareholder problem — family businesses do it better13:00 James Timpson on flogging everybody15:00 Common threads across kinder organisations17:00 Kindness to customers, not just employees18:30 The charity sector reality check21:00 Attention, meetings and How to Fix Meetings22:00 Nancy Kline's Time to Think23:00 Podcasting and the attention economy25:00 Busyness and kindness — do they mix?27:00 The kindness window and the London Tube seat28:00 Item four — the praise you never gave29:00 Busyness as a badge of honour30:00 Adam's back surgery and rebuilding slowly32:00 Carl Honoré and the slow movement33:00 Slowness is savouring, not speed34:00 Erling Kagge, the South Pole and the apple36:00 Seth Godin and Beyond Busy38:00 The advice that named the book39:00 The watermark that nearly stopped the blurb40:00 "Blurbs help the author walk taller"42:00 Kindness starts with you44:00 Abundance versus scarcity45:00 "There is enough. I am enough."46:00 Rev Up for the Week47:00 Quick-fire: book the ticket47:45 DJing at Brighton Sundae48:30 Golden rule: stay curious
👤 ABOUT GRAHAM ALLCOTTAuthor, speaker and entrepreneur. Founder of Think Productive. Author of How to Be a Productivity Ninja and Kind: The Quiet Power of Kindness at Work — 2025 Leadership Book of the Year. Resident DJ at Brighton Sundae.🌐 https://www.grahamallcott.com📧 Rev Up for the Week — free Sunday newsletter🎧 brightonsundae.com
🎙️ ABOUT PHARMA PRESCRIBEDLong-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.🌐 https://pharmaprescribed.com💼 https://www.linkedin.com/in/adamwalkerbiometrics
#GrahamAllcott #Kind #KindnessAtWork #ThinkProductive #ProductivityNinja #PharmaPrescribed #AdamWalker #PsychologicalSafety #Leadership #WorkplaceCulture #SethGodin #Busyness #SlowMovement #Trust #Wellbeing

Adam Walker interviews namesake Adam Walker; GMP, Sepsis & 900k NHS Doses a Year | Pharma Prescribed
Two Adam Walkers, one conversation. This week the host is joined by his namesake — Adam Walker, Qualified Person, Head of Development and Innovation at the North East and North Cumbria Medicines Manufacturing Centre, and co-founder of the Help Me GMP educational platform.
Adam qualified as an NHS pharmacist in 2003 and quickly realised the clean room, not the ward, was where he could do the most good. In this episode he explains the quiet revolution underway in NHS pharmaceutical manufacturing: a new hub-and-spoke model, one of four national aseptic pathfinder hubs, and a brand-new facility in Northumberland going live in 2027 — built to produce around 150,000 chemotherapy doses and up to 750,000 ready-to-administer antibiotic doses a year.
The patient impact is immediate. A ready-made antibiotic bag pulled from a fridge means the one-hour door-to-needle target for suspected sepsis is met, and nurses get 12–15 minutes per dose back for patient care.
Then the conversation turns personal. Adam shares his "why" — his mother's Grade 4 metastatic bowel cancer diagnosis in 2003, her remarkable response to the FOLFOX regimen, and the nine extra years it bought: his wedding, meeting his first son. It's why he gets up in the morning.
He also opens up on mentorship, Annex 1, and building Help Me GMP for the "TikTok generation" of pharma professionals.
Two disciplines — GMP and GCP — one shared mission: getting the right medicine to the patient at the right time.
🎧 LISTEN TO THE AUDIOSpotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjtiApple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcastPodbean: https://pharmaprescribed.podbean.comFull transcript and episode notes: https://pharmaprescribed.com/episodes
Youtube: https://youtu.be/2MoNyxxkDiE 
 
⏱️ CHAPTERS0:00 Intro0:35 Meet Adam Walker (QP)1:00 Finding pharma manufacturing9:00 Development & innovation: the NENC hub15:00 Patient impact and the sepsis window18:00 A personal why: his mother's cancer and FOLFOX21:00 Mentors and career shapers27:00 The Help Me GMP mission31:00 Creating content with AI — the GMP way33:00 Quick fire round36:00 Golden rule and wrap up
👤 ABOUT ADAM WALKER (GUEST)Qualified Person and pharmaceutical quality leader. Head of Development and Innovation at the North East and North Cumbria Medicines Manufacturing Centre, leading the build of next-generation NHS manufacturing facilities. Co-founder of Help Me GMP, delivering free, practical GMP training worldwide. NHS pharmacist since 2003, specialising in GMP manufacturing, aseptic processing and medicine supply.💼 Search "Adam Walker Help Me GMP" on LinkedIn🌐 https://www.whatisgmp.com▶️ Help Me GMP on YouTube
🎙️ ABOUT PHARMA PRESCRIBEDPharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker.🌐 https://pharmaprescribed.com▶️ https://www.youtube.com/@pharmaprescribedpodcast💼 https://www.linkedin.com/in/adam-walker-2327951/🏢 https://uk.linkedin.com/company/pharma-prescribed-podcast
#AdamWalker #HelpMeGMP #GMP #NHS #AsepticProcessing #MedicinesManufacturing #PharmaPrescribed #PatientSafety #Chemotherapy #Sepsis #QualifiedPerson #Pharma

Lisa Kerr on why 95% of eligible patients never join a clinical trial | Pharma Prescribed
Lisa Kerr is Head of Patient Engagement at Evinova, AstraZeneca's health tech business — a PhD chemist who climbed to global project director, hit a cliff edge, and came back with a mission.
In this episode Lisa talks openly about the divorce, the clinical depression, and the three months as an outpatient at the Priory that reshaped her career. She founded AstraZeneca's Safe Space employee resource group after one Workplace post she thought would end her career — and built mental health navigation tools that scaled globally.
She then turns that lived experience on the industry itself: only 5–7% of eligible patients ever join a clinical trial, and that number has barely moved in a decade despite digitisation and healthcare transformation. Lisa explains the EACH framework, why patients are the real investors in a trial (time, health, trust — given for free), and why AI has just destroyed pharma's last excuse for not designing trials with patients.
Honest, funny, and unusually direct. No soundbites, no spin.
🎧 LISTEN TO THE AUDIOSpotify: https://open.spotify.com/show/7Ks5oLfSDf0u9F1I8GUjtiApple Podcasts: https://podcasts.apple.com/gb/podcast/adam-walkers-pharma-prescribed-podcast/id1829715970Amazon Music: https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcastPodbean: https://pharmaprescribed.podbean.comFull transcript and episode notes: https://pharmaprescribed.com/episodes
⏱️ CHAPTERS0:00 Intro0:35 Meet Lisa Kerr1:30 A mission built on lived experience2:50 From PhD chemist to global project director4:20 The cliff edge: divorce, depression, the Priory5:50 "Ask people how they are twice" — the colleague who saved her8:50 The mental health access crisis11:40 Building Safe Space at AstraZeneca16:10 The navigation tools that scaled globally20:10 Purpose, energy and humour22:45 Lessons from the Priory26:40 Patient engagement: being the voice in the room29:10 The EACH framework and patients as consumers30:50 Why only 5–7% of eligible patients ever join a trial32:35 When the system fails even the well-informed35:30 AI kills the industry's last excuse38:10 Misinformation, hallucination and pharma's silence on social41:50 Quick fire round44:20 Where to find Lisa
👤 ABOUT LISA KERRHead of Patient Engagement at Evinova (AstraZeneca). PhD chemist, 20+ years across global pharma and health tech. Founder of AstraZeneca's Safe Space ERG and the Evinova I&D network. Advocate for LGBTQIA+ rights, neurodivergent communities and trauma survivors. Charity trustee. Singer in rock and pop covers band The Torrists.💼 Search "Lisa Kerr" on LinkedIn🎸 The Torrists — on Instagram and Facebook
🎙️ ABOUT PHARMA PRESCRIBEDPharma Prescribed is the podcast where leaders, innovators and hidden voices in healthcare open up. No soundbites, no spin. Just raw insight, one prescription at a time. Hosted by biometrics consultant Adam Walker.🌐 https://pharmaprescribed.com▶️ https://www.youtube.com/@pharmaprescribedpodcast

Alen Hadzic on Engineering Clinical Trial Enrollment with Predictive AI | Pharma Prescribed
Alen Hadzic — founder and CEO of Clinical Trial Scan, Olympic fencer and patent-pending inventor of Dyno AI — joins Adam Walker for one of the most data-driven conversations on the Pharma Prescribed Podcast.
Alen's path to clinical trials started with Facebook ads, a friend called Artyom, and $5–7 million in advertising spend across 50 studies. When margins got squeezed, he didn't walk away — he took control of the funnel, built a predictive AI that calculates the true cost per enrollment before a study starts, and filed a patent on the methodology.
His golden rule: just show up. Kobe Bryant said it best.
🎧 LISTEN ON YOUR PREFERRED APPSpotify → https://open.spotify.com/episode/3sRsBTqdRbRK7sTzhjSWi1?si=TQgkyijsS-WTX7OXGwoC0g
Apple Podcasts → https://podcasts.apple.com/gb/podcast/alen-hadzic-on-engineering-clinical-trial-enrollment/id1829715970?i=1000775363752 Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcastPodbean → https://pharmaprescribed.podbean.com/
Youtube → https://youtu.be/02tkkvXY4VU?si=-6PyzKLqEqWK-E-T
 
📖 WHAT WE COVER- $5–7M in Facebook ad data across 50+ clinical trials — and what it revealed- Dyno AI: predicting the true cost per enrolled patient before you spend a dollar- The seven funnel steps from ad click to enrollment — and why each probability matters- Monte Carlo simulations for enrollment cost forecasting- Why a 10% deviation in one funnel step can double your cost per patient- Hot leads vs cold databases: why speed to call changes everything- 70% answer rate across nine calls — but only if you call in the evening- The Colombia call centre: American Colombians running three call blocks a day- Why most AI in clinical trials doesn't work — and how Alen's actually does- Olympic fencing, coach Alexey Cheremsky and waking up at 4am- Bosnian father, French literature PhD mother and never listening to advice- Recording a death metal album while scaling a clinical trial startup- Patent pending on the cost per enrollment methodology
⏱️ CHAPTERS0:00 Introduction & podcast mission1:00 Meet Alen Hadzic — founder of Clinical Trial Scan2:00 Former Olympic fencer, musician, writer, drummer3:00 How sport and consulting gave him a unique perspective4:00 Finding clinical trials through Spravato and COVID5:00 Affiliate marketing: running ads for the biggest recruitment vendors6:00 $5–7M in advertising data across 50+ studies7:00 Margins squeezed — so he took control of the funnel8:00 Understanding the real cost per enrollment9:00 Why questionnaire design kills your ad performance10:00 Cost per lead by city: $66 Detroit, $52 Miami12:00 The algorithm, keywords and why simple ads outperform13:00 Dyno AI: protocol upload to funnel prediction14:00 The seven funnel steps — call to enrollment16:00 Dropout, concierge and speed to call17:00 Why cold databases fail and hot leads win18:00 48-hour contact window — the critical threshold19:00 End-to-end delivery and site-centric pricing20:00 Small funnel deviations = massive cost changes21:00 Colombia call team: bilingual, driven, three blocks a day24:00 Initiation fees, difficulty scores and transparent pricing25:00 AI hype reality check — "we are not an AI company"26:00 Why small databases won't save your study27:00 How Dyno's AI actually trains and improves28:00 Monte Carlo simulations and confidence intervals29:00 Expanding: Colombia, Brazil and LATAM31:00 Mentors: coach Cheremsky, parents, the clinical trials community34:00 Quick-fire: let life do the work — stop forcing outcomes36:00 Show up, good attitude, bring yourself37:00 Music: Iron Maiden changed everything — recording an album38:00 Golden rule: show up — Kobe Bryant said it best41:00 dyno.clinicaltrialscan.ai and closing thanks
👤 ABOUT ALEN HADZICFounder and CEO of Clinical Trial Scan. Creator of Dyno AI (patent pending). Former Olympic fencer. Columbia University. Vlerick Business School.🌐 https://dyno.clinicaltrialscan.ai💼 Search "Alen Hadzic" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBEDLong-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.🌐 https://pharmaprescribed.com💼 https://www.linkedin.com/in/adam-walker-2327951/
#AlenHadzic #ClinicalTrialScan #DynoAI #PatientRecruitment #ClinicalTrials #PharmaPrescribed #AdamWalker #CostPerEnrollment #MonteCarlo #DigitalAdvertising #FacebookAds #OlympicFencer #LifeSciences #ClinicalResearch #PatentPending

Dr. Pat Boulogne on Functional Medicine, Fasting Since 17 on Zero Medications @71 | Pharma Prescribed
Dr.Pat Boulogne — performance optimisation strategist, functional medicine expert and bestselling author — joins Adam Walker for one of the most practical wellbeing conversations on the Pharma Prescribed Podcast.
Dr.Pat is 71, takes zero medications, works 14-hour days with full mental clarity, and has spent 30+ years helping high performers close the gap between where they are and where they want to be. Her father wanted her to be an electrical engineer. She chose to become an engineer of life and health instead.
Her approach is pharma unprescribed.
🎧 LISTEN ON YOUR PREFERRED APPSpotify → https://open.spotify.com/episode/3Xda2P6nkvkSzHwKyRr02f?si=8sT0tSfNQf-E1m6MApUnwQApple Podcasts → https://podcasts.apple.com/gb/podcast/dr-pat-boulogne-on-functional-medicine-fasting-since/id1829715970?i=1000774232267Amazon Music → https://music.amazon.com/podcasts/1a43eb87-b83e-441d-9a87-321263e3f821/adam-walker%E2%80%99s-pharma-prescribed-podcast
📖 WHAT WE COVER- 71 years old, zero medications, 14-hour days — how she does it- Root cause medicine vs symptom masking: the sleep medication story- Intermittent fasting since age 17 — before anyone called it that- How to pair foods so your body isn't stressed — and why timing matters- Alkaline tide: why you crash after lunch and what to do about it- The three brains: lizard, mammalian and conscious — and how they talk- Why affirmations only work if you ask "why" at the end- The organic broccoli dating analogy — and the woman who stole it- "If it's brown, don't eat it in the morning"- Adam's back surgery, the body keeping score and the V-shaped trees- Be true to yourself — the golden rule
⏱️ CHAPTERS0:00 Introduction & podcast mission1:00 Meet Dr.Pat Boulogne — performance optimisation strategist2:00 Mission: saving lives through physical, mental and emotional health3:00 From electrical engineering to engineer of life and health4:00 71, zero medications, sharp brain — how5:00 University of Michigan and the question that got her uninvited6:00 Outside-the-box medicine and why she never looked back7:00 85% of headaches are metabolically involved8:00 The sleep medication story: first full night in weeks9:00 Intermittent fasting since 17 — one meal a day10:00 Water intake calculated by body weight11:00 Brain performance: when to study, eat and exercise12:00 Alkaline tide: why food makes you crash13:00 In-a-Gadda-da-Vida: exercise to a heartbeat14:00 Bread, self-regulation and pushing away from the table15:00 Scarpetta la piatra: how Italians eat bread right16:00 Microbiome, labels and knowing your food sources17:00 Corn syrup, ultra-processed foods and why labels lie18:00 Injured gut: probiotics won't save you19:00 Dairy: raw milk vs dead milk — source matters21:00 Body signals: bloating, cramps and what they mean22:00 Foot adjustment: five days pain-free after 20 years23:00 Adam's back surgery and the body keeping score25:00 Three brains: lizard, mammalian and conscious26:00 Affirmations plus "why" — rewiring the mammalian brain28:00 The V-shaped trees, the ring and Adam's daily ritual30:00 Golfer's pickup and protecting your pelvis32:00 "I open the fridge and look in the medicine cabinet"34:00 Organic broccoli is like dating — the story36:00 Food as medicine: lifestyle not diet37:00 "Play with your grandkids or watch them?"39:00 Quick-fire: go to school sooner, say what you think40:00 Honesty, integrity, action — and cooking41:00 Golden rule: be true to yourself
👤 ABOUT DR. PAT BOULOGNEPerformance optimisation strategist. Functional medicine expert. Author of Why Are You Sick, Fat, and Tired? 30+ years clinical experience.📚 Amazon UK and US💼 Search "Dr Pat Boulogne" on LinkedIn
🎙️ ABOUT PHARMA PRESCRIBEDLong-form conversations with leaders in clinical research, digital health and mental wellbeing, hosted by Adam Walker.🌐 https://pharmaprescribed.com💼 https://www.linkedin.com/in/adam-walker-2327951/
#DrPatBoulogne #FunctionalMedicine #PerformanceOptimisation #PharmaPrescribed #AdamWalker #IntermittentFasting #RootCause #Wellbeing #Nutrition #ThreeBrains #Affirmations #OrganicFood #Microbiome #GutHealth #HealthyAging